Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endoscopic Mucosal Resection Versus Endoscopic subMucosal Dissection fOr Removal of Visible Lesions in Barrett's Esophagus With Early Neoplasia: a Randomized Controlled Trial

NCT05276791 is registered in ClinicalTrials.gov with St. Antonius Hospital as lead sponsor.

NCT NCT05276791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05276791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endoscopic Mucosal Resection Versus Endoscopic subMucosal Dissection fOr Removal of Visible Lesions in Barrett's Esophagus With Early Neoplasia: a Randomized Controlled Trial
Lead sponsor
St. Antonius Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
January 17, 2023
Completion date
December 1, 2028
Enrollment
331 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

barrett adenocarcinoma, barretts esophagus with dysplasia, esophageal cancer